CAS: 171047-47-5 - Ladirubicin
Formel:C29H31NO11S
InChl:InChI=1S/C29H31NO11S/c1-13-28(41-42(3,37)38)18(30-8-9-30)10-20(39-13)40-19-12-29(36,14(2)31)11-17-21(19)27(35)23-22(26(17)34)24(32)15-6-4-5-7-16(15)25(23)33/h4-7,13,18-20,28,34-36H,8-12H2,1-3H3/t13-,18-,19-,20-,28+,29-/m0/s1
InChI Key:InChIKey=VMDWTZZCNDEKIO-CBNJBKGYSA-N
SMILES:O=C1C=2C=CC=CC2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(C(=O)C)CC4OC5OC(C)C(OS(=O)(=O)C)C(N6CC6)C5
- Synonyme:
- 5,12-Naphthacenedione, 9-acetyl-7-[[3-(1-aziridinyl)-2,3,6-trideoxy-4-O-(methylsulfonyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S,9S)-
- PNU 159548
- FCE 28729
- 5,12-Naphthacenedione, 9-acetyl-7-[[3-(1-aziridinyl)-2,3,6-trideoxy-4-O-(methylsulfonyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
- (7S,9S)-9-Acetyl-7-[[3-(1-aziridinyl)-2,3,6-trideoxy-4-O-(methylsulfonyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Ladirubicin REF: TM-T32534CAS: 171047-47-5 | - - - | Nachfragen | Mo 10 Mär 25 |
Ladirubicin
Ref: TM-T32534
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |